Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy

Joseph D Boss, Pawan Kumar Singh, Hemang K Pandya, Joaquin Tosi, Chaesik Kim, Asheesh Tewari, Mark S Juzych, Gary W Abrams, Ashok Kumar, Joseph D Boss, Pawan Kumar Singh, Hemang K Pandya, Joaquin Tosi, Chaesik Kim, Asheesh Tewari, Mark S Juzych, Gary W Abrams, Ashok Kumar

Abstract

Purpose: To assess vitreous levels of inflammatory cytokines and neurotrophins (NTs) in diabetic retinopathy (DR) and elucidate their potential roles.

Methods: A prospective study was performed on 50 vitreous samples obtained from patients with DR (n = 22) and the nondiabetic controls (n = 28). All patients were candidates for vitrectomy. Inflammatory cytokine and NT levels were determined with ELISA. Potential source and role of NTs was determined by using human retinal Müller glia and mouse photoreceptor cells and challenging them with TNF-α or IL-1β, followed by detection of NTs and cell death.

Results: Vitreous NT levels of all DR patients were significantly higher than those of nondiabetic controls (nerve growth factor [NGF, P = 0.0001], brain-derived neurotrophic factor [BDNF, P = 0.009], neurotrophin-3 [NT-3, P < 0.0001], neurotrophin-4 [NT-4, P = 0.0001], ciliary neurotrophic factor [CNTF, P = 0.0001], and glial cell-derived neurotrophic factor [GDNF, P = 0.008]). Similarly, the levels of inflammatory mediators IL-1β (P < 0.0001), IL-6 (P = 0.0005), IL-8 (P < 0.0001), and TNF-α (P < 0.0001) were also higher in eyes with DR. Interestingly, inflammatory cytokine and NT levels, particularly TNF-α (P < 0.05), IL-8 (P < 0.004), NT-3 (P = 0.012), NGF (P = 0.04), GDNF (P = 0.005), and CNTF (P = 0.002), were higher in eyes with nonproliferative diabetic retinopathy (NPDR) than in eyes with active proliferative diabetic retinopathy (PDR). Cytokine stimulation of Müller glia resulted in production of NTs, and GDNF treatment reduced photoreceptor cell death in response to inflammation and oxidative stress.

Conclusions: Together, our study demonstrated that patients with DR have higher levels of both inflammatory cytokines and NTs in their vitreous. Müller glia could be the potential source of NTs under inflammatory conditions to exert neuroprotection.

Figures

Figure 1
Figure 1
Box-and-whisker plot analysis showing comparison of vitreous NGF, BDNF, NT-3, NT-4, CNTE, and GDNF levels in diabetics (n = 22) compared to nondiabetics (n = 28) (A) and diabetic patients with NPDR compared to active PDR (B).
Figure 2
Figure 2
Box-and-whisker plot analysis showing comparison of vitreous IL-6, IL-1β, IL-8, and TNF-α in diabetics (n = 22) compared to nondiabetics (n = 28) (A) and diabetic patients with NPDR compared to PDR (B).
Figure 3
Figure 3
Box-and-whisker plot analysis of vitreous neurotrophin (A) and inflammatory cytokine (B) levels in diabetics who have undergone peripheral retinal ablation with PRP compared to diabetics without a history of PRP.
Figure 4
Figure 4
Inflammatory cytokines induce NT production in Müller glia. Human retinal Müller glia (MIO-M1 cell line) were challenged with recombinant TNF-α or IL-1β (100 ng/mL each) (A, B), IL-4 (100 ng/mL) (C), and dexamethasone (100 μM) (D) for the indicated time points. The secretion of NTs into the conditioned media was detected by dot blot, and the intensities of the dots were quantitated by densitometric analysis, using ImageJ and presented as fold-changes (arbitrary units; AU), using a value of 1 for the control samples (B). Statistical analysis was performed by using a 1-way ANOVA (*P 

Figure 5

GDNF protects oxidative stress and…

Figure 5

GDNF protects oxidative stress and inflammation-induced photoreceptor cell death. Mouse cone photoreceptor cells…

Figure 5
GDNF protects oxidative stress and inflammation-induced photoreceptor cell death. Mouse cone photoreceptor cells (661W cell line) were challenged with H2O2 (100 μM) and TNF-α (100 ng/mL) in the presence and absence of GDNF (100 ng/mL) for 24 hours. The neuroprotective effect of GDNF was measured by measuring the cell death by TUNEL staining (blue, 4′,6-diamidino-2-phenylindole [DAPI] nuclear stain; green, TUNEL+ve cells).

Figure 6

Schematic of the relationship between…

Figure 6

Schematic of the relationship between inflammatory mediators and NTs in diabetic retinopathy. Patients…

Figure 6
Schematic of the relationship between inflammatory mediators and NTs in diabetic retinopathy. Patients with diabetic retinopathy have increased levels of inflammatory mediators in vitreous. This increased inflammatory milieu triggers the production of NTs in retinal cells, such as Müller glia, which in turn exert neuroprotective and anti-inflammatory effects to prevent neuronal cell death in the retina.
Figure 5
Figure 5
GDNF protects oxidative stress and inflammation-induced photoreceptor cell death. Mouse cone photoreceptor cells (661W cell line) were challenged with H2O2 (100 μM) and TNF-α (100 ng/mL) in the presence and absence of GDNF (100 ng/mL) for 24 hours. The neuroprotective effect of GDNF was measured by measuring the cell death by TUNEL staining (blue, 4′,6-diamidino-2-phenylindole [DAPI] nuclear stain; green, TUNEL+ve cells).
Figure 6
Figure 6
Schematic of the relationship between inflammatory mediators and NTs in diabetic retinopathy. Patients with diabetic retinopathy have increased levels of inflammatory mediators in vitreous. This increased inflammatory milieu triggers the production of NTs in retinal cells, such as Müller glia, which in turn exert neuroprotective and anti-inflammatory effects to prevent neuronal cell death in the retina.

References

    1. Klein R, Klein BE, Moss SE, Wong TY. . The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2006; 104: 98– 107.
    1. Kowluru RA, Kowluru A, Mishra M, Kumar B. . Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res. 2015; 48: 40– 61.
    1. Kowluru RA, Chan P-S. . Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007; 2007: 43603.
    1. Yu Y, Chen H, Su SB. . Neuroinflammatory responses in diabetic retinopathy. J Neuroinflamm. 2015; 12: 141.
    1. Tang J, Kern TS. . Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011; 30: 343– 358.
    1. Kumar A, Kumar A. . Role of Staphylococcus aureus virulence factors in inducing inflammation and vascular permeability in a mouse model of bacterial endophthalmitis. PLoS One. 2015; 10: e0128423.
    1. Shaw PX, Stiles T, Douglas C,et al. . Oxidative stress, innate immunity, and age-related macular degeneration. AIMS Mol Sci. 2016; 3: 196– 221.
    1. Kadlubowska J, Malaguarnera L, Waz P, Zorena K. . Neurodegeneration and neuroinflammation in diabetic retinopathy: potential approaches to delay neuronal loss. Curr Neuropharmacol. 2016; 14: 831– 839.
    1. Stem MS, Gardner TW. . Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications. Curr Med Chem. 2013; 20: 3241– 3250.
    1. Barber AJ. . A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27: 283– 290.
    1. Bikbova G, Oshitari T, Baba T, Yamamoto S. . Neurotrophic factors for retinal ganglion cell neuropathy—with a special reference to diabetic neuropathy in the retina. Curr Diabetes Rev. 2014; 10: 166– 176.
    1. Semkova I, Krieglstein J. . Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res Rev. 1999; 30: 176– 188.
    1. Abu El-Asrar AM, Mohammad G, De Hertogh G,et al. . Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy. PLoS One. 2013; 8: e65472.
    1. Nishikiori N, Mitamura Y, Tashimo A,et al. . Glial cell line-derived neurotrophic factor in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Care. 2005; 28: 2588.
    1. Singh PK, Shiha MJ, Kumar A. . Antibacterial responses of retinal Muller glia: production of antimicrobial peptides, oxidative burst and phagocytosis. J Neuroinflamm. 2014; 11: 33.
    1. Singh PK, Kumar A. . Retinal photoreceptor expresses Toll-like receptors (TLRs) and elicits innate responses following TLR land bacterial challenge. PLoS One. 2015; 10: e0119541.
    1. Singh PK, Kumar A. . Mitochondria mediates caspase-dependent and independent retinal cell death in Staphylococcus aureus endophthalmitis. Cell Death Discov. 2016; 2: 16034.
    1. Kochan T, Singla A, Tosi J, Kumar A. . Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus. Infect Immun. 2012; 80: 2076– 2088.
    1. Kumar A, Shamsuddin N. . Retinal Muller glia initiate innate response to infectious stimuli via toll-like receptor signaling. PLoS One. 2012; 7: e29830.
    1. Shamsuddin N, Kumar A. . TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. J Immunol. 2011; 186: 7089– 7097.
    1. Wilkinson CP, Ferris FL III, Klein RE,et al. . Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003; 110: 1677– 1682.
    1. Relhan N, Flynn HW Jr.. The Early Treatment Diabetic Retinopathy Study historical review and relevance to today's management of diabetic macular edema. Curr Opin Ophthalmol. 2017; 28: 205– 212.
    1. Srinivasan S, Raman R, Kulothungan V, Swaminathan G, Sharma T. . Influence of serum lipids on the incidence and progression of diabetic retinopathy and macular oedema: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular genetics Study-II [published online ahead of print May 17, 2017]. Clin Exp Ophthalmol. doi:.
    1. Takeuchi M, Sato T, Tanaka A,et al. . Elevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients. PLoS One. 2015; 10: e0137358.
    1. Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K. . Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016; 73: 1765– 1786.
    1. Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V. . Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales' disease. Retina. 2008; 28: 817– 824.
    1. Adamiec-Mroczek J, Oficjalska-Mlynczak J, Misiuk-Hojlo M. . Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: analysis of vitreous samples. Cytokine. 2010; 49: 269– 274.
    1. Zhou J, Wang S, Xia X. . Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res. 2012; 37: 416– 420.
    1. Loukovaara S, Nurkkala H, Tamene F,et al. . Quantitative proteomics analysis of vitreous humor from diabetic retinopathy patients. J Proteome Res. 2015; 14: 5131– 5143.
    1. Wykoff CC, Chakravarthy U, Campochiaro PA, Bailey C, Green K, Cunha-Vaz J. . Long-term effects of intravitreal 0.19 mg fluocinolone acetonide implant on progression and regression of diabetic retinopathy. Ophthalmology. 2017; 124: 440– 449.
    1. Taylor S, Srinivasan B, Wordinger RJ, Roque RS. . Glutamate stimulates neurotrophin expression in cultured Muller cells. Brain Res Mol Brain Res. 2003; 111: 189– 197.
    1. Calabrese F, Rossetti AC, Racagni G, Gass P, Riva MA, Molteni R. . Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci. 2014; 8: 430.
    1. Behl T, Kotwani A. . Downregulated brain-derived neurotrophic factor-induced oxidative stress in the pathophysiology of diabetic retinopathy. Can J Diabetes. 2017; 41: 241– 246.
    1. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology. 1981; 88: 583– 600.
    1. Caporali A, Pani E, Horrevoets AJG,et al. . Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ Res. 2008; 103: e15– e26.
    1. Yamashita N, Kuruvilla R. . Neurotrophin signaling endosomes: biogenesis, regulation, and functions. Curr Opin Neurobiol. 2016; 39: 139– 145.
    1. Zhang J, Zhao J, Bai Y, Huang L, Yu W, Li X. . Effects of p75 neurotrophin receptor on regulating hypoxia-induced angiogenic factors in retinal pigment epithelial cells. Mol Cell Biochem. 2015; 398: 123– 134.
    1. Sheedlo HJ, Srinivasan B, Brun-Zinkernagel AM,et al. . Expression of p75(NTR) in photoreceptor cells of dystrophic rat retinas. Brain Res Mol Brain Res. 2002; 103: 71– 79.
    1. Mysona BA, Al-Gayyar MM, Matragoon S,et al. . Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats. Diabetologia. 2013; 56: 2329– 2339.
    1. Casaccia-Bonnefil P, Gu C, Chao MV. . Neurotrophins in cell survival/death decisions. Adv Exp Med Biol. 1999; 468: 275– 282.
    1. Hernández C, Dal Monte M, Simó R, Casini G. . Neuroprotection as a therapeutic target for diabetic retinopathy. J Diabetes Res. 2016; 2016: 9508541.
    1. Hernandez C, Simo R. . Neuroprotection in diabetic retinopathy. Curr Diab Rep. 2012; 12: 329– 337.
    1. Honjo M, Tanihara H, Kido N, Inatani M, Okazaki K, Honda Y. . Expression of ciliary neurotrophic factor activated by retinal Muller cells in eyes with NMDA- and kainic acid-induced neuronal death. Invest Ophthalmol Vis Sci. 2000; 41: 552– 560.
    1. Harada T, Harada C, Kohsaka S,et al. . Microglia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci. 2002; 22: 9228– 9236.
    1. Kumar A, Pandey RK, Miller LJ, Singh PK, Kanwar M. . Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis. Crit Rev Immunol. 2013; 33: 119– 135.
    1. Jiang Y, Wei N, Zhu J,et al. . Effects of brain-derived neurotrophic factor on local inflammation in experimental stroke of rat. Mediators Inflamm. 2010; 2010: 372423.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel